- Global Pharma News & Resources

Press Releases

Date Title Company
29-Jul-2018 Children account for nearly one-third of identified trafficking victims globally UNICEF Canada
29-Jul-2018 Expanding the Boundaries of Genomic Detection, Cancer Therapies, Population Health, and Pain Treatment at the 70th AACC Annual Scientific Meeting AACC
30-Jul-2018 Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology Merck Life Science
30-Jul-2018 BlueWind Medical Appoints Dr. Roger R. Dmochowski, MD, MMHC, as Chief Medical Officer BlueWind Medical
30-Jul-2018 Apple Rehab Mystic Ensuring Elderly Don't Suffer Heat Stroke in Summer Apple Rehab Inc
30-Jul-2018 Shire plc : Miscellaneous Shire plc
30-Jul-2018 New STING study opens up multi-billion dollar cancer immunotherapy market for LIDDS unique NanoZolid® technology LIDDS AB
30-Jul-2018 Herantis Pharma Oyj: Manager's Transactions - Pekka Simula Herantis Pharma Oyj
30-Jul-2018 4D Announces Publication of Data Showing Potential of Single Bacterial Strains From the Human Gut Microbiota to Serve as Novel HDAC Inhibitors 4D pharma plc
30-Jul-2018 Chi-Med Reports 2018 Interim Results and Updates Shareholders on Key Clinical Programs Chi-Med
30-Jul-2018 Almac Group Launches GMP High Throughput Peptide Manufacturing Service Almac Group
30-Jul-2018 Almirall receives positive CHMP opinion for new anti-IL23 tildrakizumab for the treatment of patients with moderate-to-severe chronic plaque psoriasis Almirall
30-Jul-2018 CHMP Issues Positive Opinion Recommending DARZALEX® (daratumumab) for Front Line Multiple Myeloma CHMP
30-Jul-2018 Repurchased Shares in Karo Pharma During Week 30 2018 Karo Pharma
30-Jul-2018 FDA Accepts File for Cladribine Tablets as Potential Treatment for Relapsing Forms of Multiple Sclerosis EMD Serono
30-Jul-2018 Health Hope Releases Healthy Products and Upgrades its Ego System to Become AI Healthy Medical Intelligent Brain Health Hope
30-Jul-2018 Nucleix Receives €2.5 Million in Funding from the European H2020 / EIC pilot SME Instrument Programme, for Its Lung Cancer Diagnostic Tool Nucleix
30-Jul-2018 Sublimity Therapeutics Appoints Jesse W. Hall as Chief Medical Officer Sublimity Therapeutics Limited
30-Jul-2018 European Medicines Agency Adopts Positive Opinion for KEYTRUDA® (pembrolizumab) Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer MSD